About
The Biologit platform, designed by pharmacovigilance experts, provides a comprehensive solution for literature monitoring in the pharmaceutical industry. It optimizes compliance and simplifies processes through its AI-driven technology, cutting manual effort significantly. The platform meets global regulatory requirements and features dashboards and analytics that offer compliance and transparency. With a commitment to delivering efficiency and control, Biologit serves pharma teams looking for reliable optimization in their monitoring efforts.
Related Vendors
Citrusˣ provides a unified platform for validating and mitigating AI and model risk at scale. The solution offers live alerts when models make mistakes, enabling immediate responses and the prevention of costly failures. Citrusˣ ensures continuous oversight to align with regulatory standards and business goals, making the deployment of AI and large language models (LLMs) safer and more efficient. Their comprehensive approach helps organizations manage AI risks effectively while meeting compliance requirements.
Agent Trust Gate™ (ATG) is a UK-built, local-first technical demonstrator for pre-action authority control of consequential AI-agent actions. It verifies agent standing, trusted authority evidence, scope, limits and required human approval against the exact proposed action before issuing an action-bound GatePass or recorded refusal. ATG is designed to complement existing identity, authority and approval infrastructure rather than replace it, using trusted upstream evidence to decide whether a specific AI action is authorised here and now.
TrustPath is a SaaS platform for enterprise AI risk management and AI vendor compliance. It provides a central TrustAI Center to manage AI vendors, monitor deployment status, compliance health, and recent changes. The platform helps customers assess and onboard AI vendors, perform consistent and auditable risk evaluations, and monitor vendor performance and AI usage risks. TrustPath highlights EU AI Act compliance and includes capabilities to quickly assess and monitor vendors for EU AI Act requirements and identify AI risks (including mentions of shadow AI detection). The offering targets both AI builders and enterprise adopters, aiming to simplify vendor oversight and scale AI adoption while maintaining visibility and control over AI deployments.